Dr. Jatinder Lamba receives $3.3 million NCI grant for pediatric AML research
The $3.3 million, five-year R01 grant from National Cancer Institute will support Lamba's research of the biology of acute myeloid leukemia.
All Posts by
The $3.3 million, five-year R01 grant from National Cancer Institute will support Lamba's research of the biology of acute myeloid leukemia.
Dr. Richard Marrero and Francisco Marchi were honored with abstract awards at the ASH Annual Meeting in New Orleans on Dec. 10.
UF Health honored 33 endowed professors and chairs across the six academic colleges at a special Celebrating Distinction ceremony on Oct. 13.
A team led by UF researchers has used genome-wide CRISPR/cas9 screening to identify genes that are sensitive or resistant to etoposide, a chemotherapy drug used to treat pediatric acute myeloid leukemia, or AML.
Santevecchi offers insight into the COVID-19 medication Paxlovid and whether it will work against omicron subvariants like BA.5.
Dr. Miller will be an academic and administrative leader in Orlando, and she will oversee the Doctor of Pharmacy program on campus.
The newly awarded titles began on July 1, 2022.
The UF College of Pharmacy secured a record $32.3 million in research funding last year.
The UF study used machine learning to retrospectively evaluate outcomes for more than 700 intensive care unit patients who were infected with hospital-acquired and ventilator-associated pneumonia.
Wiisanen will assume broad responsibilities in leading the college’s online graduate education, continuing education, entrepreneurial clinical programs, video production and enrollment marketing teams.